Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Burman

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Lancet (London, England)|September 21, 2002
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trialDebra Benator, Mondira Bhattacharya, Lorna Bozeman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 23, 2025
Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort studyTomas O Jensen, Shweta Sharma, Anchalee Avihingsanon, et al.
AIDS (London, England)|November 26, 2019
Impact of early antiretroviral treatment on sexual behaviour: a randomised comparisonFiona C Lampe, Alison J Rodger, William Burman, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 2011
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmapPayam Nahid, Jussi Saukkonen, William R Mac Kenzie, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Lancet (London, England)|September 21, 2002
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trialDebra Benator, Mondira Bhattacharya, Lorna Bozeman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 23, 2025
Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort studyTomas O Jensen, Shweta Sharma, Anchalee Avihingsanon, et al.
AIDS (London, England)|November 26, 2019
Impact of early antiretroviral treatment on sexual behaviour: a randomised comparisonFiona C Lampe, Alison J Rodger, William Burman, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 2011
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmapPayam Nahid, Jussi Saukkonen, William R Mac Kenzie, et al.
Pageof 4